These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8430920)

  • 1. Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults.
    Hannuksela M; Kalimo K; Lammintausta K; Mattila T; Turjanmaa K; Varjonen E; Coulie PJ
    Ann Allergy; 1993 Feb; 70(2):127-33. PubMed ID: 8430920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months.
    Diepgen TL;
    Pediatr Allergy Immunol; 2002 Aug; 13(4):278-86. PubMed ID: 12390444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind study of cetirizine in atopic eczema in children.
    La Rosa M; Ranno C; Musarra I; Guglielmo F; Corrias A; Bellanti JA
    Ann Allergy; 1994 Aug; 73(2):117-22. PubMed ID: 8067594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of cetirizine hydrochloride on the pruritus of cats with atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover study.
    Wildermuth K; Zabel S; Rosychuk RA
    Vet Dermatol; 2013 Dec; 24(6):576-81, e137-8. PubMed ID: 24112588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 2, randomized, double-blind, placebo-controlled, 4-week study to evaluate the safety and efficacy of OPA- 15406 (difamilast), a new topical selective phosphodiesterase type-4 inhibitor, in Japanese pediatric patients aged 2-14 years with atopic dermatitis.
    Saeki H; Baba N; Oshiden K; Abe Y; Tsubouchi H
    J Dermatol; 2020 Jan; 47(1):17-24. PubMed ID: 31713267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cetirizine in dogs with chronic atopic dermatitis: a randomized, double blind, placebo-controlled trial.
    Hsiao YH; Chen C; Willemse T
    J Vet Sci; 2016 Dec; 17(4):549-553. PubMed ID: 27297415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel elastic vesicle-based topical formulation of cetirizine dihydrochloride for treatment of atopic dermatitis.
    Goindi S; Kumar G; Kumar N; Kaur A
    AAPS PharmSciTech; 2013 Dec; 14(4):1284-93. PubMed ID: 23959702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis.
    Van Leent EJ; Gräber M; Thurston M; Wagenaar A; Spuls PI; Bos JD
    Arch Dermatol; 1998 Jul; 134(7):805-9. PubMed ID: 9681343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream.
    Chunharas A; Wisuthsarewong W; Wananukul S; Viravan S
    J Med Assoc Thai; 2002 Apr; 85(4):482-7. PubMed ID: 12118496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child.
    Simons FE
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):433-40. PubMed ID: 10452767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up.
    Warner JO;
    J Allergy Clin Immunol; 2001 Dec; 108(6):929-37. PubMed ID: 11742270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients.
    Rukwied R; Heyer G
    Exp Dermatol; 1999 Feb; 8(1):39-45. PubMed ID: 10206720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of canine atopic dermatitis with cetirizine, a second generation antihistamine: a single-blinded, placebo-controlled study.
    Cook CP; Scott DW; Miller WH; Kirker JE; Cobb SM
    Can Vet J; 2004 May; 45(5):414-7. PubMed ID: 15206590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.
    Kabashima K; Matsumura T; Komazaki H; Kawashima M;
    N Engl J Med; 2020 Jul; 383(2):141-150. PubMed ID: 32640132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
    Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
    Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child.
    Pediatr Allergy Immunol; 1998 Aug; 9(3):116-24. PubMed ID: 9814724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term evaluation of the impact of the h1-receptor antagonist cetirizine on the behavioral, cognitive, and psychomotor development of very young children with atopic dermatitis.
    Stevenson J; Cornah D; Evrard P; Vanderheyden V; Billard C; Bax M; Van Hout A;
    Pediatr Res; 2002 Aug; 52(2):251-7. PubMed ID: 12149503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis: a patient- and examiner-blinded, randomized, placebo-controlled, crossover trial.
    Pfab F; Kirchner MT; Huss-Marp J; Schuster T; Schalock PC; Fuqin J; Athanasiadis GI; Behrendt H; Ring J; Darsow U; Napadow V
    Allergy; 2012 Apr; 67(4):566-73. PubMed ID: 22313287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Simpson EL; Sinclair R; Forman S; Wollenberg A; Aschoff R; Cork M; Bieber T; Thyssen JP; Yosipovitch G; Flohr C; Magnolo N; Maari C; Feeney C; Biswas P; Tatulych S; Valdez H; Rojo R
    Lancet; 2020 Jul; 396(10246):255-266. PubMed ID: 32711801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.